| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/15/2007 | US7217573 Method of inspecting a DNA chip |
| 05/15/2007 | US7217572 Modulation of HIF1α and HIF2α expression |
| 05/15/2007 | US7217568 Insertion catenin into cells; controlling apoptosis; antitumor agents, anticancer agents |
| 05/15/2007 | US7217567 Sealed vials containing lyophilized eukaryotic cells for use as controls in diagnostic assays wherein the cells after 4 weeks at 20 degrees C. have more than 50% of their 18S rRNA intact as measured by gel electrophoresis. |
| 05/15/2007 | US7217565 Contacting, binding to monoclonal antibodies; therapy for central nervous system disorders |
| 05/15/2007 | US7217562 Preparing a fluidic device for detection of restriction fragment length polymorphism; high throughput macromolecular analysis using diffraction gradient lithography gradient interfaces |
| 05/15/2007 | US7217555 isolated human NAALAD-ase (N-acetylated alpha-linked acidic dipeptidases) L protein; |
| 05/15/2007 | US7217552 expression vector; host cell transformed with gene; culturing cell to produce polypeptide that has an activity of converting a sulfated fucogalactan into a smaller molecule |
| 05/15/2007 | US7217542 Identifying preferential nucleotide sequences in nucleic acid mixture; genomic sequencing and proteomics |
| 05/15/2007 | US7217538 Nucleic acid molecule containing a nucleotide sequence encoding CaEss1 (candida albicans) gene or having at least 70% homology; antiproliferative application |
| 05/15/2007 | US7217536 Medium and method for detecting/identifying microorganisms |
| 05/15/2007 | US7217535 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
| 05/15/2007 | US7217534 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 05/15/2007 | US7217533 P38 MAPK pathway predicts endocrine-resistant growth of human breast cancer and provides a novel diagnostic and treatment target |
| 05/15/2007 | US7217532 Methods for detecting DNA damage and screening for cancer therapeutics |
| 05/15/2007 | US7217530 Process for detecting PrP using a macrocyclic adjuvant ligand |
| 05/15/2007 | US7217528 isolated antibody that specifically binds to polypeptides for diagnosing, preventing and treating autoimmune, cancer and transplant disorders; wound healing agents |
| 05/15/2007 | US7217527 Assay for phosphodiesterase function |
| 05/15/2007 | US7217526 identifying T cells in a sample that become activated in the presence of a vaccinia or variola virus using immunogenic mutant or fragment of peptide 165 as a CD8 T cell epitope |
| 05/15/2007 | US7217525 Identifying a compound controlling the gene expression, for treating nervous system disorders, with a gene therapy |
| 05/15/2007 | US7217524 Method for diagnosing aplasia of corpus callosum |
| 05/15/2007 | US7217523 Nucleoside phosphoramidates and nucleoside phosphoramidases |
| 05/15/2007 | US7217522 extending a primer annealed to polynucleotides having predetermined sequence characteristics to incorporate a predetermined terminator having a capture moiety; capturing; melting the captured polynucleotides from the extended primer |
| 05/15/2007 | US7217521 Interaction between the selected splicing factors and the transcripts is detected by capturing the complexes on an array of probes and detecting the presence of bound complexes; splicing factor is an SR protein or hnRNP protein |
| 05/15/2007 | US7217520 Microwell biochip |
| 05/15/2007 | US7217519 enable the specific detection of the H. capsulatum chitin synthase 2 intron sequences as a means to detect infection with the pathogen H. capsulatum |
| 05/15/2007 | US7217518 Detecting the binding of analytes of interest to aptamers by measuring changes in fluorescence anisotropy |
| 05/15/2007 | US7217517 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 05/15/2007 | US7217516 Methods and kits comprising AFLP primers, and ramp primers with a part complementary to a compound microsatellite repeat and an anchor part complementary to nucleotides adjacent to the repeat |
| 05/15/2007 | US7217515 HURP gene as a molecular marker for bladder cancer |
| 05/15/2007 | US7217514 Generation of variation in preferential nucleotide seuences; obtain nucleotide sequences, incubate with variation mixture, recover variant products |
| 05/15/2007 | US7217513 Apparatus and method for isolating a nucleic acid from a sample |
| 05/15/2007 | US7217512 Substrate with a guanidino, pyridyl or thiouronium group |
| 05/15/2007 | US7217511 Methods of increasing antibiotic production in Streptomyces by deletion of the scbA gene |
| 05/15/2007 | US7217510 Detecting biological warfare agent; obtain nucleotide sequences, incubate with primers, amplify, determine mass of amplification product, compare to control, classify amplification product |
| 05/15/2007 | US7217509 Isolating preferential polynucleotide sequences from library; obtain cellular chromatin, incubate with probe, fragment nucleotide sequences, recover marked polynucleotides |
| 05/15/2007 | US7217508 In vitro diagnosis of a Human Immunodeficiency Virus Type 1 by detecting HIV-1 nucleic acid present in cell-free supernatant of a biological fluid containing cells infected with HIV-1 |
| 05/15/2007 | US7217507 Using affinity chromatography to characterize and isolated ligand and bindng partner complexes |
| 05/15/2007 | US7217506 Mutational profiles in HIV-1 protease correlated with phenotypic protease inhibitor resistance |
| 05/15/2007 | US7217415 NADP-dependent glyceraldehyde-3-phosphate dehydrogenase for therapeutic use |
| 05/15/2007 | US7217412 IL-17C related mammalian cytokine polypeptides |
| 05/15/2007 | US7216792 Self assembled nano-devices using DNA |
| 05/15/2007 | US7216671 Microfabricated elastomeric valve and pump systems |
| 05/15/2007 | CA2416886C Reagent delivery device and method of use |
| 05/15/2007 | CA2404293C Variants of an erwinia-type creatinase |
| 05/15/2007 | CA2347345C Process for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olefinic double bonds |
| 05/15/2007 | CA2332131C Serine protease-specific monoclonal antibody and utilization thereof |
| 05/15/2007 | CA2260940C Methods for isolating nucleic acids using alkaline protease |
| 05/15/2007 | CA2249736C Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection |
| 05/15/2007 | CA2236848C Electrochemical method |
| 05/15/2007 | CA2179890C Assays for immunosuppressants |
| 05/15/2007 | CA2159822C Process for inhibiting the transcription of genes |
| 05/15/2007 | CA2155744C Preparation of nucleic acids using acid protease |
| 05/15/2007 | CA2149419C Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds |
| 05/15/2007 | CA2087958C Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 05/15/2007 | CA2083259C Nucleotide sequence of soybean stearoyl-acp desaturase gene |
| 05/15/2007 | CA2071879C Glutamate receptor compositions and methods |
| 05/15/2007 | CA2011633C Intercellular adhesion molecule - 2 and its binding ligands |
| 05/10/2007 | WO2007053785A2 Method for early detection of various cancers and gastrointestinal disease and monitoring of transplanted organs. |
| 05/10/2007 | WO2007053767A1 Uses of anti-cd40 antibodies |
| 05/10/2007 | WO2007053752A2 Computerized systems and methods for assessment of genetic test results |
| 05/10/2007 | WO2007053732A2 Promoter polymorphisms of the blys gene and use in diagnostic methods |
| 05/10/2007 | WO2007053719A2 Chemically cleavable 3'-o-allyl-dntp-allyl-fluorophore fluorescent nucleotide analogues and related methods |
| 05/10/2007 | WO2007053659A2 Method of screening for hepatocellular carcinoma |
| 05/10/2007 | WO2007053644A2 Comparative ligand mapping from mhc class i positive cells |
| 05/10/2007 | WO2007053595A2 Methods for identification of susceptibility to inflammatory disease |
| 05/10/2007 | WO2007053497A2 Analyte sensor and method of making it |
| 05/10/2007 | WO2007053491A2 Method and kit for evaluating rna quality |
| 05/10/2007 | WO2007053480A2 Protein demethylases comprising a jmjc domain |
| 05/10/2007 | WO2007053281A2 Mems actuator and method of manufacture for mems particle sorting device |
| 05/10/2007 | WO2007053107A1 Endotoxin analysis |
| 05/10/2007 | WO2007052841A1 Platelet aggregation inhibitor composition |
| 05/10/2007 | WO2007052765A1 Rna extraction method and rna detection method |
| 05/10/2007 | WO2007052740A1 Equol level regulator |
| 05/10/2007 | WO2007052646A1 Method for measuring triglyceride in low-density lipoprotein and kit for measurement |
| 05/10/2007 | WO2007052635A1 Method for rapid detection of oral bacterium |
| 05/10/2007 | WO2007052561A1 Method for prevention of myocardial hypertrophy by inhibiting interaction between slim1 and usp, and agent for prevention of myocardial hypertrophy |
| 05/10/2007 | WO2007052466A1 Method of screening substance useful in treating disease with the use of gpr40 and phospholipase |
| 05/10/2007 | WO2007052101A1 Linear amplification of rna using a high-heel primer |
| 05/10/2007 | WO2007052078A2 Improvements in sequencing |
| 05/10/2007 | WO2007052008A1 Membrane assay method |
| 05/10/2007 | WO2007052006A1 Method of preparing libraries of template polynucleotides |
| 05/10/2007 | WO2007051961A1 Nitrate test method |
| 05/10/2007 | WO2007051863A2 Method and device for the detection of molecular interactions |
| 05/10/2007 | WO2007051859A1 Device and method for the automatic isolation and purification of nucleic acids from any complex starting materials |
| 05/10/2007 | WO2007051836A2 Compositions for treating dermatological and neurological disorders |
| 05/10/2007 | WO2007051781A1 Novel cxc-chemokine antagonists |
| 05/10/2007 | WO2007051605A2 Methods for determining the cleavability of substrates |
| 05/10/2007 | WO2007051603A2 Kit comprising 2, 4- dichlorophenoxyacetic acd derivatives and antibodies for highly sensitive detection assays |
| 05/10/2007 | WO2007051303A1 MODIFIED siRNA MOLECULES AND USES THEREOF |
| 05/10/2007 | WO2007051257A1 Method for monitoring hydrolytic activity |
| 05/10/2007 | WO2007051256A1 Method for monitoring protein digestion |
| 05/10/2007 | WO2007051248A1 Single nucleotide polymorphisms (snp) and their association with tick resistance in bovine animals |
| 05/10/2007 | WO2007035962A3 Gene blocking method |
| 05/10/2007 | WO2007035763A3 Methods for detecting and characterizing microorganisms |
| 05/10/2007 | WO2007028845A3 Diagnostic kit and method for the quantitative determination of the expression of the maxi-k channel |
| 05/10/2007 | WO2007028580A3 Single receptor assays for immunosuppressive drugs |
| 05/10/2007 | WO2007019283A3 Identification of 5-lipoxygenase effects on obesity and insulin resistance |
| 05/10/2007 | WO2007014951A3 Methods for the screening of antibacterial substances |
| 05/10/2007 | WO2007010268A3 Oligonucleotides |